CCL22 and mycosis fungoides: In addition, bexarotene reduces the production of C–C motif chemokine (CCL)22 from tumor-associated macrophages (TAMs), thereby suppressing the recruitment of CTCL cells and regulatory T cells in the lesional skin of MF [12].